- Home
- CANF vs DTST Comparison
CANF vs DTST Comparison
Compare CANF & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CANF | DTST |
|---|---|---|
| Founded | 1994 | 2001 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 7.1M |
| IPO Year | 2011 | 2012 |
Fundamental Metrics
Financial Performance| Metric | CANF | DTST |
|---|---|---|
| Price | $1.95 | $3.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 39.1K | 20.2K |
| Earning Date | 09-08-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3671.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,382,929.00 |
| Revenue This Year | N/A | $8.47 |
| Revenue Next Year | N/A | $20.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.17 | $2.75 |
| 52 Week High | $10.40 | $5.15 |
Technical Indicators
Market Signals| Indicator | CANF | DTST |
|---|---|---|
| Relative Strength Index (RSI) | 27.14 | 53.33 |
| Support Level | N/A | $2.82 |
| Resistance Level | $2.27 | $3.63 |
| Average True Range (ATR) | 0.08 | 0.21 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 11.11 | 61.04 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc and corporate segment. It generates maximum revenue from the Nexxis Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.